Cupps Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-40,743
Closed -$1.37M 190
2016
Q1
$1.37M Buy
+40,743
New +$1.28M 0.26% 112
2015
Q4
Sell
-78,345
Closed -$2.47M 190
2015
Q3
$2.47M Sell
78,345
-61,114
-44% -$2.98M 0.33% 92
2015
Q2
$6.74M Buy
+139,459
New +$5.88M 0.65% 66

Other funds holding PGEN

Cupps Capital Management's PGEN Position: Q2 2016 in Review

Cupps Capital Management sold out of Precigen (PGEN) in Q2 2016, closing a stake of 40,743 shares — an estimated $1.37M sold.

Cupps Capital Management first reported a position in PGEN in Q2 2015 and held it in 3 quarters. The position peaked at $6.74M in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Cupps Capital Management reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Cupps Capital Management sold 40,743 Precigen shares in Q2 2016, an estimated $1.37M.
  • Cupps Capital Management first reported a position in Precigen in Q2 2015 and held it in 3 quarters.
  • Cupps Capital Management's Precigen position peaked at $6.74M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Cupps Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.